• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢他啶/阿维巴坦用于治疗由产肺炎克雷伯菌碳青霉烯酶(KPC)的细菌引起的难治性菌血症、伴有椎前脓肿的椎间盘炎/骨髓炎以及双侧腰大肌脓性肌炎。

Ceftazidime/Avibactam for Refractory Bacteremia, Vertebral Diskitis/Osteomyelitis with Pre-Vertebral Abscess and Bilateral Psoas Pyomyositis Secondary to Klebsiella Pneumoniae Carbapenemase-Producing Bacteria (KPC).

作者信息

De León-Borrás Rafael, Álvarez-Cardona Julio, Vidal Jorge A, Guiot Humberto M

机构信息

Division of Infectious Diseases, Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, PR; Department of Internal Medicine, VA Caribbean Healthcare System, San Juan, PR.

Department of Radiology, University of Puerto Rico Medical Sciences Campus, San Juan, PR; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

出版信息

P R Health Sci J. 2018 Jun;37(2):128-131.

PMID:29905925
Abstract

A 36-year-old man was admitted to the intensive care unit due to diabetic ketoacidosis and pneumonia requiring mechanical ventilation. Three weeks after admission, he developed a refractory bacteremia with Klebsiella pneumoniae carbapenemase-producing bacteria (KPC). He remained febrile and with bacteremia for six weeks despite therapy with polymyxin B, carbapenems, and amikacin. Imaging studies looking for deep-seated infection revealed vertebral L1-L2 diskitis and osteomyelitis with pre-vertebral abscess and bilateral psoas pyomyositis that were not amenable for drainage. In view of the refractory infection and the activity against KPC described in the literature, we decided to switch the patient to ceftazidime/avibactam. After six weeks of therapy, there was complete resolution of the infectious processes. We present an instance of clinical success with ceftazidime/avibactam for the treatment of refractory KPC bacteremia, vertebral diskitis and osteomyelitis with pre-vertebral abscess and bilateral psoas pyomyositis. This experience serves as reference to support treatment with ceftazidime/avibactam in similar complicated cases.

摘要

一名36岁男性因糖尿病酮症酸中毒和需要机械通气的肺炎入住重症监护病房。入院三周后,他出现了由产碳青霉烯酶肺炎克雷伯菌(KPC)引起的难治性菌血症。尽管接受了多粘菌素B、碳青霉烯类药物和阿米卡星治疗,但他持续发热并菌血症六周。寻找深部感染的影像学检查显示L1-L2椎体椎间盘炎和骨髓炎,伴有椎前脓肿和双侧腰大肌脓性肌炎,无法进行引流。鉴于难治性感染以及文献中描述的对KPC的活性,我们决定将患者的治疗改为头孢他啶/阿维巴坦。经过六周的治疗,感染过程完全消退。我们展示了头孢他啶/阿维巴坦成功治疗难治性KPC菌血症、椎体椎间盘炎和骨髓炎伴椎前脓肿和双侧腰大肌脓性肌炎的临床实例。这一经验可为类似复杂病例中使用头孢他啶/阿维巴坦治疗提供参考。

相似文献

1
Ceftazidime/Avibactam for Refractory Bacteremia, Vertebral Diskitis/Osteomyelitis with Pre-Vertebral Abscess and Bilateral Psoas Pyomyositis Secondary to Klebsiella Pneumoniae Carbapenemase-Producing Bacteria (KPC).头孢他啶/阿维巴坦用于治疗由产肺炎克雷伯菌碳青霉烯酶(KPC)的细菌引起的难治性菌血症、伴有椎前脓肿的椎间盘炎/骨髓炎以及双侧腰大肌脓性肌炎。
P R Health Sci J. 2018 Jun;37(2):128-131.
2
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing .头孢他啶-阿维巴坦对产碳青霉烯酶的. 的体外和体内杀菌活性。
Antimicrob Resist Infect Control. 2018 Nov 21;7:142. doi: 10.1186/s13756-018-0435-9. eCollection 2018.
3
Pharmacokinetics of Ceftazidime-Avibactam in Two Patients With KPC-Producing Klebsiella pneumoniae Bacteremia and Renal Impairment.头孢他啶-阿维巴坦在两名产KPC肺炎克雷伯菌菌血症和肾功能损害患者中的药代动力学
Pharmacotherapy. 2016 Nov;36(11):e172-e177. doi: 10.1002/phar.1840. Epub 2016 Oct 31.
4
Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.头孢他啶-阿维巴坦治疗持续中性粒细胞减少兔产碳青霉烯酶肺炎克雷伯菌肺炎的药代动力学和疗效。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02157-19.
5
Combination treatment with extended-infusion ceftazidime/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient.延长输注头孢他啶/阿维巴坦联合治疗肾和胰腺移植患者产KPC-3的肺炎克雷伯菌败血症
Int J Antimicrob Agents. 2016 Aug;48(2):225-7. doi: 10.1016/j.ijantimicag.2016.06.002. Epub 2016 Jun 23.
6
Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing .头孢他啶-阿维巴坦单药及与厄他培南、磷霉素和替加环素联合治疗产碳青霉烯酶肠杆菌科细菌的活性
Microb Drug Resist. 2019 Nov;25(9):1357-1364. doi: 10.1089/mdr.2018.0234. Epub 2019 Jul 11.
7
Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York City.头孢他啶-阿维巴坦对纽约市流行的肺炎克雷伯菌临床分离株(包括携带KPC的分离株)的活性。
Microb Drug Resist. 2018 Jan/Feb;24(1):35-39. doi: 10.1089/mdr.2016.0293. Epub 2017 Jun 7.
8
Changing Characteristics and Susceptibility to Ceftazidime/Avibactam of Bloodstream Extensively Drug-Resistant from a Greek Intensive Care Unit.希腊重症监护病房血流感染的广泛耐药对头孢他啶/阿维巴坦的耐药特征及敏感性变化
Microb Drug Resist. 2020 Jan;26(1):28-37. doi: 10.1089/mdr.2019.0090. Epub 2019 Aug 6.
9
Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Bacteremia and Abscess in a Liver Transplant Recipient.美罗培南-法硼巴坦作为肝移植受者中头孢他啶-阿维巴坦耐药菌血症和脓肿的挽救疗法。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01551-18. Print 2019 Jan.
10
Ceftazidine-avibactam salvage therapy in newborn with KPC-producing Klebsiella pneumoniae invasive infections.头孢他啶-阿维巴坦挽救治疗产KPC肺炎克雷伯菌侵袭性感染的新生儿。
Minerva Anestesiol. 2019 Jul;85(7):804-805. doi: 10.23736/S0375-9393.19.13521-3.

引用本文的文献

1
Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections.骨与关节感染中耐多药革兰氏阴性病原体的抗菌治疗选择
Pathogens. 2025 Feb 1;14(2):130. doi: 10.3390/pathogens14020130.
2
Disseminated organ and tissue infection secondary to carbapenem-resistant Klebsiella pneumoniae bloodstream infection for acute lymphoblastic leukemia treated with ceftazidime-avibactam: Two case reports.用头孢他啶-阿维巴坦治疗急性淋巴细胞白血病继发于耐碳青霉烯肺炎克雷伯菌血流感染的播散性器官和组织感染:两例报告
Medicine (Baltimore). 2025 Jan 10;104(2):e41195. doi: 10.1097/MD.0000000000041195.
3
Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature.
头孢他啶-阿维巴坦治疗骨髓炎:病例系列及文献综述
Antibiotics (Basel). 2023 Aug 17;12(8):1328. doi: 10.3390/antibiotics12081328.
4
Carbapenem-Resistant Spondylodiscitis Treated with Ceftazidime-Avibactam: A Case Report with Literature Review.用头孢他啶-阿维巴坦治疗耐碳青霉烯类脊柱椎间盘炎:1例病例报告并文献复习
Infect Drug Resist. 2023 Aug 14;16:5309-5317. doi: 10.2147/IDR.S421209. eCollection 2023.
5
Carbapenem-Resistant Osteomyelitis Treated with Ceftazidime-Avibactam in an Infant: A Case Report.婴儿碳青霉烯类耐药性骨髓炎采用头孢他啶-阿维巴坦治疗:一例报告
Infect Drug Resist. 2021 Aug 11;14:3109-3113. doi: 10.2147/IDR.S320056. eCollection 2021.
6
Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review.头孢他啶-阿维巴坦用于治疗治疗选择有限的严重革兰氏阴性感染:一项系统文献综述
Infect Dis Ther. 2021 Dec;10(4):1989-2034. doi: 10.1007/s40121-021-00507-6. Epub 2021 Aug 11.